BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 23, 2016
View Archived Issues
New animal models of ocular diseases presented at ARVO
Read More
Aptahem collaborates with Nencki Institute of Experimental Biology on APTA-1
Read More
Regen Biopharma starts preclinical development of universal donor immunotherapy
Read More
Selecta Biosciences obtains exclusive license for gene therapy vector Anc-80
Read More
Response, safety data updated for cancer vaccine INO-3112 in HPV-associated HNSCC trial
Read More
Otsuka Pharmaceutical reviews pipeline highlights of first quarter 2016
Read More
Eisai reviews pipeline highlights of fourth quarter of fiscal 2015
Read More
FDA grants orphan drug designation to ANAVEX 2-73 for the treatment of Rett syndrome
Read More
Halozyme anti-EGFR ADC is active against tumors with resistance mutations
Read More
Stratatech initiates first-in-human study of ExpressGraft-C9T1 skin tissue for diabetic foot ulcers
Read More
Ohio State University patents MPS1 inhibitors
Read More
University Health Network discloses RIP-2 inhibitors
Read More
DS Biopharma to develop DS-102 for COPD as well as NASH
Read More
Wisconsin Alumni Research Foundation reports HIV protease inhibitors
Read More
Xencor generates bispecific antibodies targeting prostate-specific membrane antigen and CD3
Read More
Ube Industries presents CDK7 inhibitors
Read More
Bristol-Myers Squibb describes alpha7 nicotinic acetylcholine receptor ligands
Read More
EMA accepts MAA for Pfizer's Trumenba
Read More
Avalon Ventures and GSK form new company, PDI Therapeutics
Read More
Acorda Therapeutics discontinues development of Plumiaz
Read More
NanoCarrier describes NC-6201, an anticancer product based on the ADCM platform
Read More
Cyramza receives additional indication approval for colorectal cancer in Japan
Read More
Pfizer initiates phase I trial of PF-06817024
Read More
NMDA receptor antagonist for colitis
Read More
Ustekinumab receives FDA orphan designation for pediatric Crohn's disease
Read More